IL103730A0 - Therapeutic and diagnostic methods based on tissue-specific nt-3 expression and receptor binding - Google Patents

Therapeutic and diagnostic methods based on tissue-specific nt-3 expression and receptor binding

Info

Publication number
IL103730A0
IL103730A0 IL103730A IL10373092A IL103730A0 IL 103730 A0 IL103730 A0 IL 103730A0 IL 103730 A IL103730 A IL 103730A IL 10373092 A IL10373092 A IL 10373092A IL 103730 A0 IL103730 A0 IL 103730A0
Authority
IL
Israel
Prior art keywords
therapeutic
tissue
expression
specific
receptor binding
Prior art date
Application number
IL103730A
Other languages
English (en)
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of IL103730A0 publication Critical patent/IL103730A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL103730A 1991-11-12 1992-11-12 Therapeutic and diagnostic methods based on tissue-specific nt-3 expression and receptor binding IL103730A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79085791A 1991-11-12 1991-11-12

Publications (1)

Publication Number Publication Date
IL103730A0 true IL103730A0 (en) 1993-04-04

Family

ID=25151941

Family Applications (1)

Application Number Title Priority Date Filing Date
IL103730A IL103730A0 (en) 1991-11-12 1992-11-12 Therapeutic and diagnostic methods based on tissue-specific nt-3 expression and receptor binding

Country Status (6)

Country Link
CN (1) CN1073264A (xx)
AU (1) AU3130493A (xx)
IL (1) IL103730A0 (xx)
PT (1) PT101051A (xx)
WO (1) WO1993009798A1 (xx)
ZA (1) ZA928730B (xx)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2269075A1 (en) * 1996-10-16 1998-04-23 Regeneron Pharmaceuticals, Inc. Method of enhancing the delivery of growth factors
WO1998021245A1 (de) * 1996-11-08 1998-05-22 Roche Diagnostics Gmbh eOCHAFFINE ANTIKÖRPER GEGEN HUMAN-BDNF, VERFAHREN ZU IHRER HERSTELLUNG UND VERWENDUNG
EP1173768B1 (en) * 1999-05-03 2006-10-25 Evotec AG Methods of diagnosing, prognosing, monitoring the progression or evaluating of a treatment of depression on basis of increased cerebrospinal fluid levels of neurotrophin 3
EP1050758A1 (en) * 1999-05-03 2000-11-08 Evotec BioSystems AG Methods of diagnosing or treating neuropsychiatric diseases on basis of increased cerebrospinal fluid levels of neurotrophin 3
US6548062B2 (en) * 2000-02-29 2003-04-15 Cephalon, Inc. Method of treating cancer with anti-neurotrophin agents
CN110812532A (zh) * 2019-08-20 2020-02-21 中山大学 一种靶向促进皮质脊髓束连接以修复脊髓损伤的组织工程支架的构建方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4868107A (en) * 1986-11-18 1989-09-19 The United States Of America As Represented By The Department Of Health And Human Services Method for detecting antibodies against neuropeptides and drugs in human body fluid

Also Published As

Publication number Publication date
WO1993009798A1 (en) 1993-05-27
AU3130493A (en) 1993-06-15
ZA928730B (en) 1993-05-10
PT101051A (pt) 1994-02-28
CN1073264A (zh) 1993-06-16

Similar Documents

Publication Publication Date Title
IL105930A0 (en) Therapeutic respiration device
GB2219735B (en) Reclining device
EP0875199A4 (en) DEVICE FOR MEASURING THE CONDITION OF THE ORGANISM AND DEVICE GIVING RELAXATION INSTRUCTIONS
GB9500368D0 (en) Medicine injection device
IL109094A0 (en) Human tnf muteins
EP0768038A3 (en) Shortening and its use
GB9320322D0 (en) Coupling apparatus and seat structure
EP0708237A4 (en) FUEL TREATMENT DEVICE
EP0386246A4 (en) Device for local heating and stereoresonator for local heating
IL101678A0 (en) Membrane bound probes and their construction
IL106037A0 (en) Therapeutic and diagnostic methods based on neurotrophin-4-expression
AU115939S (en) Combined infusion device and charger unit
EP0538659A3 (en) Extracorporal therapy device
EP0711830A3 (en) Murine and human galanin receptor
GB2262698B (en) Flea-rid and grooming apparatus and methods
GB9626446D0 (en) Therapeutic device
IL103730A0 (en) Therapeutic and diagnostic methods based on tissue-specific nt-3 expression and receptor binding
EP0792282A4 (en) BOMBESIN AND ENDOTHELIN RECEPTOR OF HUMAN ORIGIN
GB9002217D0 (en) Back rehabilitation procedure and means
GB9120768D0 (en) Diagnostic and prognastic materials and methods
IL116226A0 (en) Substituted n-phenyl and n-heteroarylalkylcarbamates their preparation and use
ZA976547B (en) Lipid-binding proteins and their therapeutic and diagnostic use
EP0587806A4 (en) THERAPEUTIC AND DIAGNOSTIC PROCEDURES BASED ON NEUROTROPHIN-4 EXPRESSION.
EP0803570A4 (en) MUTANT DNA RECEPTOR OF HUMAN INSULIN
ZA923716B (en) Therapeutic and diagnostic methods based on neurotrophin-4 expression